BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 92.73
+0.02 (0.02%)
At close: Sep 12, 2025
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 39.17 billion as of September 12, 2025. Its market cap has increased by 245.74% in one year.
Market Cap
39.17B
Enterprise Value
40.21B
Revenue
1.16B
Ranking
n/a
PE Ratio
391.79
Stock Price
92.73
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 39.17B, an increase of 212.11%. That is a compound annual growth rate of 21.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 39.17B | 207.27% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | 18.78B | 44.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 454.92B |
| WuXi AppTec | 304.20B |
| Shenzhen Mindray Bio-Medical Electronics | 294.78B |
| Sichuan Biokin Pharmaceutical | 137.55B |
| Shanghai United Imaging Healthcare | 127.10B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.31B |
| Aier Eye Hospital Group | 121.96B |
| Yunnan Baiyao Group Co.,Ltd | 106.73B |